1987: Arix Bioscience, Vadim Alexandre on Synairgen and Glen Goodman

Arix Bioscience talk about one of their portfolio companies, Amplyx Pharmaceuticals positive topline data from its Phase 2 clinical trial. Vadim Alexandre discusses Synairgen. Glen Goodman, author of, "The Crypto Trader", covers this week’s Bitcoin price action and news.